Under Pressure, Pfizer Pulls Jarvik's Lipitor Ads
Ian Read, Pfizer's president of worldwide pharmaceutical operations, released a statement Monday endorsing Jarvik's reputation as a medical expert and regretting the controversy surrounding Jarvik's promotional role for the blockbuster cholesterol drug.
“Going forward,” Read said, “we commit to ensuring there is greater clarity in our advertising regarding the presentation of spokespeople.”
Already a subscriber? Click here to login